Back to Agenda
Session 6: Global Perspectives: Impact of Biosimilars Around the World – What Have we Learned so Far?
Session Chair(s)
Mauricio Ede, MD, PhD
Chief Medical & Scientific Officer
Sandoz Canada Inc., Canada
Hillel P Cohen, PhD
Executive Director, Scientific Affairs
Sandoz Inc., United States
The Biosimilar “Wave” has arrived in the US, but they have been around for quite some time elsewhere. Join us to learn more about international perspectives and insights on implementation, market uptake and the impact on healthcare systems in Europe, Canada, and Latin America, and how these experiences may influence the US.
Learning Objective : At the conclusion of this session, participants should be able to: - Identify best practices developed in foreign markets
- Assess the applicability of insights to the US Marketplace
- Devise plans for implementation while leveraging clinical experience obtained in markets similar to the US
Speaker(s)
Speaker
Fabrício Oliveira
ANVISA, Brazil
Head of Biologic Products and Advanced Therapy Medicinal Products Office
Speaker
Dustin Loomes, MD
UBC, Canada
Clinical Assistant Professor; Director, Vancouver Island IBD Clinic
Speaker
Merete Lund Hetland, MD, PhD
DANBIO and University of Copenhagen, Denmark
Consultant in Rheumatology, Professor
Speaker
Thiago Mares Guia, MD, PhD
Bionovis, Brazil
Executive Vice President
Have an account?